Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Porkka, Kimmo
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
E
Kiesewetter B
,
Cherny NI
,
Boissel N
,
Cerisoli F
,
Dafni U
,
de Vries EGE
,
Ghia P
,
Gökbuget N
,
González-Calle V
,
Huntly B
, et al.
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies.
ESMO Open. 2020;5(1).
PubMed
Google Scholar
O
Wei AH
,
Döhner H
,
Pocock C
,
Montesinos P
,
Afanasyev B
,
Dombret H
,
Ravandi F
,
Sayar H
,
Jang J-H
,
Porkka K
, et al.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
N Engl J Med. 2020;383(26):2526-2537.
PubMed
Google Scholar
P
Döhner H
,
Wei AH
,
Roboz GJ
,
Montesinos P
,
Thol FR
,
Ravandi F
,
Dombret H
,
Porkka K
,
Sandhu I
,
Skikne BS
, et al.
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine.
Blood. 2022.
PubMed
Google Scholar
Ngai LLam
,
Hanekamp D
,
Janssen F
,
Carbaat-Ham J
,
Hofland MAM
,
Fayed MMHE
,
Kelder A
,
van Marsbergen LOudshoorn-
,
Scholten WJ
,
Snel AN
, et al.
Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial.
Blood. 2023.
PubMed
Google Scholar
R
Vikkula J
,
Uusi-Rauva K
,
Ranki T
,
Toppila I
,
Aalto-Setälä M
,
Pousar K
,
Vassilev L
,
Porkka K
,
Silvennoinen R
,
Brück O
.
Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland.
Future Oncol. 2023.
PubMed
Google Scholar